<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Brett Gardiner

Brett Gardiner
Brett is a Director and heads up our specialist market access team. Brett has managed and contributed to the development of pricing and reimbursement strategies for pharmaceuticals and medical devices in all stages of the product life-cycle across all major European markets, US, Japan, Canada as well as many emerging markets. Brett has particular experience in asset valuation and value communication as well as more complex pricing research: moderation of payer and KOL dyads, focus groups, advisory boards, mock formulary committees and P&R negotiation simulations.

Recent Posts

News

Events: EHA Virtual Congress 2021 round up

We were delighted that a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients and their..

Read more

Events: EHA Virtual Congress 2021

We’re delighted to announce a Research Partnership study into the burden of illness in newly diagnosed Multiple Myeloma patients & their..

Read more
1